IMPACT OF TARGET SPECIFIC ORAL ANTICOAGULANTS ON QUALITY OF LIFE
Author(s)
Cheng W, Rash C, Patel P, Gratie D, Bathija S, Pickard AS, Berbaum M, Hellenbart E, McDowell M, Khan M, Shapiro N, Galanter W, Stamos T, Nutescu E
University of Illinois at Chicago, Chicago, IL, USA
OBJECTIVES: The aims of this study were to compare patient outcomes associated with TSOAC and warfarin in terms of quality of life (QoL). METHODS: We conducted a prospective, cross-sectional cohort study in an inner-city population treated with warfarin or a TSOAC for more than 3 months. The Duke Anticoagulation and Satisfaction Scale (DASS) was used to assess the anticoagulation-related QoL. Multivariate linear regression analysis was conducted to evaluate the association between TSOAC and QoL, adjusted for potential confounders. RESULTS: A total of 138 consecutive patients were enrolled in the study, 73 in the warfarin group and 65 in the TSOAC group. Patients treated with a TSOAC were older (63.2±
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV107
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Cardiovascular Disorders